These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 18525017
1. Central G-alpha subunit protein-mediated control of cardiovascular function, urine output, and vasopressin secretion in conscious Sprague-Dawley rats. Wainford RD, Kurtz K, Kapusta DR. Am J Physiol Regul Integr Comp Physiol; 2008 Aug; 295(2):R535-42. PubMed ID: 18525017 [Abstract] [Full Text] [Related]
2. Chronic high-NaCl intake prolongs the cardiorenal responses to central N/OFQ and produces regional changes in the endogenous brain NOP receptor system. Wainford RD, Kapusta DR. Am J Physiol Regul Integr Comp Physiol; 2009 Feb; 296(2):R280-8. PubMed ID: 18987291 [Abstract] [Full Text] [Related]
3. Centrally administered nociceptin/orphanin FQ (N/OFQ) evokes bradycardia, hypotension, and diuresis in mice via activation of central N/OFQ peptide receptors. Burmeister MA, Kapusta DR. J Pharmacol Exp Ther; 2007 Jul; 322(1):324-31. PubMed ID: 17452419 [Abstract] [Full Text] [Related]
4. Nociceptin/orphanin FQ (N/OFQ)-evoked bradycardia, hypotension, and diuresis are absent in N/OFQ peptide (NOP) receptor knockout mice. Burmeister MA, Ansonoff MA, Pintar JE, Kapusta DR. J Pharmacol Exp Ther; 2008 Sep; 326(3):897-904. PubMed ID: 18539652 [Abstract] [Full Text] [Related]
5. Functional selectivity of central Gα-subunit proteins in mediating the cardiovascular and renal excretory responses evoked by central α(2) -adrenoceptor activation in vivo. Wainford RD, Kapusta DR. Br J Pharmacol; 2012 May; 166(1):210-20. PubMed ID: 21895632 [Abstract] [Full Text] [Related]
7. Central administration of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)-NH2 and orphanin FQ/nociceptin (OFQ/N) produce similar cardiovascular and renal responses in conscious rats. Kapusta DR, Chang JK, Kenigs VA. J Pharmacol Exp Ther; 1999 Apr; 289(1):173-80. PubMed ID: 10087001 [Abstract] [Full Text] [Related]
8. Cardiovascular and renal responses produced by central orphanin FQ/nociceptin occur independent of renal nerves. Kapusta DR, Kenigs VA. Am J Physiol; 1999 Oct; 277(4):R987-95. PubMed ID: 10516236 [Abstract] [Full Text] [Related]
9. Tonic nociceptinergic inputs to neurons in the hypothalamic paraventricular nucleus contribute to sympathetic vasomotor tone and water and electrolyte homeostasis in conscious rats. Krowicki ZK, Kapusta DR. J Pharmacol Exp Ther; 2006 Apr; 317(1):446-53. PubMed ID: 16407463 [Abstract] [Full Text] [Related]
10. Hypothalamic paraventricular nucleus G alpha q subunit protein pathways mediate vasopressin dysregulation and fluid retention in salt-sensitive rats. Wainford RD, Kapusta DR. Endocrinology; 2010 Nov; 151(11):5403-14. PubMed ID: 20861238 [Abstract] [Full Text] [Related]
11. The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats. Leggett JD, Harbuz MS, Jessop DS, Fulford AJ. Neuroscience; 2006 Sep 15; 141(4):2051-7. PubMed ID: 16784820 [Abstract] [Full Text] [Related]
12. Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ). Kapusta DR, Sezen SF, Chang JK, Lippton H, Kenigs VA. Life Sci; 1997 Sep 15; 60(1):PL15-21. PubMed ID: 8995537 [Abstract] [Full Text] [Related]
13. Nociceptin/orphanin FQ modulates the cardiovascular, but not renal, responses to stress in spontaneously hypertensive rats. Kapusta DR, Dayan LA, Kenigs VA. Clin Exp Pharmacol Physiol; 2002 Mar 15; 29(3):254-9. PubMed ID: 11906494 [Abstract] [Full Text] [Related]
14. Cardiovascular and renal effects of nociceptin/orphanin FQ: a new mediator to target? Doggrell SA. Curr Opin Investig Drugs; 2007 Sep 15; 8(9):742-9. PubMed ID: 17729186 [Abstract] [Full Text] [Related]
15. Role of endogenous nociceptin in the regulation of arginine vasopressin release in conscious rats. Kakiya S, Murase T, Arima H, Yokoi H, Iwasaki Y, Miura Y, Oiso Y. Endocrinology; 2000 Dec 15; 141(12):4466-71. PubMed ID: 11108256 [Abstract] [Full Text] [Related]
16. Comparative biochemical and pharmacological characterization of a novel, NOP receptor selective hexapeptide, Ac-RYYRIR-ol. Bojnik E, Babos F, Fischetti C, Magyar A, Camarda V, Borsodi A, Bajusz S, Calo' G, Benyhe S. Brain Res Bull; 2010 Mar 16; 81(4-5):477-83. PubMed ID: 19800951 [Abstract] [Full Text] [Related]
17. Central nociceptin/orphanin FQ system elevates food consumption by both increasing energy intake and reducing aversive responsiveness. Olszewski PK, Grace MK, Fard SS, Le Grevès M, Klockars A, Massi M, Schiöth HB, Levine AS. Am J Physiol Regul Integr Comp Physiol; 2010 Aug 16; 299(2):R655-63. PubMed ID: 20427724 [Abstract] [Full Text] [Related]
18. Involvement of the neuropeptide nociceptin/orphanin FQ in kainate seizures. Bregola G, Zucchini S, Rodi D, Binaschi A, D'Addario C, Landuzzi D, Reinscheid R, Candeletti S, Romualdi P, Simonato M. J Neurosci; 2002 Nov 15; 22(22):10030-8. PubMed ID: 12427860 [Abstract] [Full Text] [Related]
19. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor. Calo G, Rizzi A, Rizzi D, Bigoni R, Guerrini R, Marzola G, Marti M, McDonald J, Morari M, Lambert DG, Salvadori S, Regoli D. Br J Pharmacol; 2002 May 15; 136(2):303-11. PubMed ID: 12010780 [Abstract] [Full Text] [Related]
20. Distinct effect of intracerebroventricular and intrathecal injections of nociceptin/orphanin FQ in the rat formalin test. Wang JL, Zhu CB, Cao XD, Wu GC. Regul Pept; 1999 Feb 05; 79(2-3):159-63. PubMed ID: 10100930 [Abstract] [Full Text] [Related] Page: [Next] [New Search]